Meget sjældent kan patienter, som tager Temodal eller lignende medicin, have en lille risiko for at udvikle en sekundær kræftform, inklusiv leukæmi.
In very rare cases, patients receiving Temodal and medicines like it may have a small risk of developing secondary cancers, including leukaemia.